Fujian Wanchen Biotechnology Co Ltd
SZSE:300972
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Fujian Wanchen Biotechnology Co Ltd
SZSE:300972
|
CN |
|
N
|
Nanjing Public Utilities Development Co Ltd
SZSE:000421
|
CN |
|
QAF Ltd
SGX:Q01
|
SG |
|
Ritesh Properties and Industries Ltd
BSE:526407
|
IN |
|
Okamura Corp
TSE:7994
|
JP |
|
E
|
Eat & Beyond Global Holdings Inc
CNSX:EATS
|
CA |
|
Quidelortho Corp
F:QL1A
|
US |
|
G
|
Guangdong Hongjing Optoelectronic Technology Inc
SZSE:301479
|
CN |
|
Narasaki Sangyo Co Ltd
TSE:8085
|
JP |
|
Z
|
Zapf Creation AG
XMUN:ZPF
|
DE |
|
S
|
Sheela Foam Ltd
BSE:540203
|
IN |
|
Amana inc
TSE:2402
|
JP |
|
Vistra Corp
NYSE:VST
|
US |
|
Ivanhoe Mines Ltd
TSX:IVN
|
CA |
|
Otto Energy Ltd
ASX:OEL
|
AU |
|
D
|
Daiichi Commodities Co Ltd
TSE:8746
|
JP |
Wall Street
Price Targets
Price Targets Summary
Fujian Wanchen Biotechnology Co Ltd
According to Wall Street analysts, the average 1-year price target for
Fujian Wanchen Biotechnology Co Ltd
is 247.44 CNY
with a low forecast of 192.91 CNY and a high forecast of 289.8 CNY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Fujian Wanchen Biotechnology Co Ltd's stock price target?
Price Target
247.44
CNY
According to Wall Street analysts, the average 1-year price target for
Fujian Wanchen Biotechnology Co Ltd
is 247.44 CNY
with a low forecast of 192.91 CNY and a high forecast of 289.8 CNY.
What is Fujian Wanchen Biotechnology Co Ltd's Revenue forecast?
Projected CAGR
31%
For the last 10 years the
compound annual growth rate for
Fujian Wanchen Biotechnology Co Ltd's revenue is
73%.
The projected
CAGR
for the next 3 years is
31%.
What is Fujian Wanchen Biotechnology Co Ltd's Operating Income forecast?
Projected CAGR
56%
For the last 10 years the
compound annual growth rate for
Fujian Wanchen Biotechnology Co Ltd's operating income is
39%.
The projected
CAGR
for the next 4 years is
56%.
What is Fujian Wanchen Biotechnology Co Ltd's Net Income forecast?
Projected CAGR
107%
For the last 10 years the
compound annual growth rate for
Fujian Wanchen Biotechnology Co Ltd's net income is
24%.
The projected
CAGR
for the next 3 years is
107%.